Post-Authorisation Safety Studies have been confirmed as one of the main tools required by regulatory agencies (EMA) to support the evidence of the drug safety. Discussing the regulatory evolution and the use of observational research methodology in this context, the workshop aims to highlight the key factors that may transform a regulatory need into a successful opportunity to fill significant data gaps. Some example from MediNeos expirience in conducting these type of studies.
Speaker: Christian Amici, MediNeos Clinical Project Portfolio Manager
To register: write to email@example.com
The webinar is free and reserved to MediNeos clients